Develop Better LNP-Based Genetic Medicines
Lipid nanoparticle (LNP)-based genetic medicines are one of the most advanced non-viral genetic drug delivery systems available. However, LNP-related impurities can compromise the integrity and safety of genetic medicine products if they are not effectively characterized and removed.
By gaining a deeper insight into the critical quality attributes (CQAs) of your LNP-based products, its possible to accelerate development of new therapeutics such as vaccines and gene editing technologies.
This content pack contains a variety of webinar and technical note resources to support you in building better genetic medicine products.
Download this content pack to discover:
- Optimized methods for impurity and integrity analysis
- Simple, fast and robust purity testing and degradation monitoring methods
- Better LNP handling methods for superior product quality